Takeda Pharmaceutical (TAK) Change in Taxes (2018 - 2025)

Takeda Pharmaceutical's Change in Taxes history runs 6 years deep, the most recent figure standing at -$27.5 million for Q1 2025.

• In Q1 2025, Change in Taxes rose 90.84% year-over-year to -$27.5 million; the TTM figure through Mar 2025 stood at -$612.1 million (down 9.39% YoY), while the FY2025 annual figure was $439.5 million, up 169.33% from the prior year.
• Change in Taxes was -$27.5 million for Q1 2025 at Takeda Pharmaceutical, down from $16.9 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $126.8 million in Q1 2023 to a low of -$301.0 million in Q4 2023.
• Historically, Change in Taxes has averaged -$95.0 million across 4 years, with a median of -$56.2 million in 2022.
• Biggest YoY gain for Change in Taxes was 105.62% in 2024; the steepest drop was 336.87% in 2024.
• A 4-year view of Change in Taxes shows it stood at -$84.9 million in 2022, then sank by 254.52% to -$301.0 million in 2023, then surged by 105.62% to $16.9 million in 2024, then plunged by 262.76% to -$27.5 million in 2025.
• The last three Change in Taxes figures came in at -$27.5 million (Q1 2025), $16.9 million (Q4 2024), and -$300.5 million (Q1 2024), per Business Quant data.